ResearcherFirst Hospital of Lanzhou UniversityActive in the last 2 years
Zhengfeng Wang
Matched on ORCID iD 0000-0002-4077-337X; OpenAlex author ID A5101572935. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper
Papers 5
- Establishment and characterization of the PDAC-X3 cell line: a novel Chinese-origin pancreatic ductal adenocarcinoma cell line. Co-author DOI 10.1007/s13577-024-01100-y↗
- Pancreatic stellate cells in pancreatic cancer: as potential targets for future therapy. Co-author DOI 10.3389/fonc.2023.1185093↗
- Glucose metabolism and tumour microenvironment in pancreatic cancer: A key link in cancer progression. Co-author DOI 10.3389/fimmu.2022.1038650↗
- miR-365 secreted from M2 Macrophage-derived extracellular vesicles promotes pancreatic ductal adenocarcinoma progression through the BTG2/FAK/AKT axis. Co-author DOI 10.1111/jcmm.16405↗
- MiR-142-3p targeting NUCKS1 inhibits proliferation and invasion of pancreatic cancer cells. Co-author DOI 10.1080/21691401.2019.1652629↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ru He · 2 shared papers, 2022–2023 · strength 0.42
- Wence Zhou · 2 shared papers, 2021–2023 · strength 0.40
- Wence Zhou · 2 shared papers, 2022–2024 · strength 0.33
- Hao Xu · 2 shared papers, 2021–2024 · strength 0.32
- Paper Establishment and characterization of the PDAC-X3 cell line: a novel Chinese-origin pancreatic ductal adenocarcinoma ce… DOI 10.1007/s13577-024-01100-y↗
- Paper miR-365 secreted from M2 Macrophage-derived extracellular vesicles promotes pancreatic ductal adenocarcinoma progressio… DOI 10.1111/jcmm.16405↗
- Changpeng Chai · 1 shared paper, 2024 · strength 0.18
- Huan Tang · 1 shared paper, 2024 · strength 0.18
- Bo Zhang · 1 shared paper, 2024 · strength 0.18
- Cheng Yu · 1 shared paper, 2024 · strength 0.18
- Xin Li · 1 shared paper, 2022 · strength 0.16
- Huaqing Shi · 1 shared paper, 2022 · strength 0.16
- Shi Dong · 1 shared paper, 2022 · strength 0.16
- Fanghong Wang · 1 shared paper, 2020 · strength 0.15
- Kexiang Zhu · 1 shared paper, 2020 · strength 0.15
- Chunlu Dong · 1 shared paper, 2021 · strength 0.14
- Hui Zhang · 1 shared paper, 2021 · strength 0.14
- Xin Li · 1 shared paper, 2021 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.